Avita Medical | 1811094D - Le Bénéfice D'Exploitation





Le Bénéfice D'Exploitation Changement Date
Accuray USD 4.71M 6.86M 2024-12
Celltrion KRW 12.9B 822.77M 2026-03
Clinuvel Pharmaceuticals AUD 13.51M 15.95M 2025-12
Cochlear AUD 261.1M 135.55M 2025-12
CSL USD 2.64B 1.97B 2025-12
Cspc Pharmaceutical CNY 206.26M 1.02B 2025-12
Deva Holding AS TRY 964.87M 240.32M 2023-09
Dianthus Therapeutics USD -46.53M 23.01M 2026-03
Divis Laboratories Ltd INR 8.14B 420M 2026-03
Kangmei Pharma CNY -10.94M 15.75M 2026-03
Knight Therapeutics CAD 6.21M 3.27M 2025-12
Laboratorios Farma EUR 135.05M 49.84M 2023-12
Malin Corporation EUR -1.1M 400K 2024-12
Mayne Pharma AUD -3.3M 15.67M 2024-06
Medical Developments International AUD -36K 444K 2025-12
Nanosonics AUD 9.12M 3.82M 2025-12
Neuren Pharmaceuticals AUD 17.01M 11.56M 2025-12
Organigram Holdings CAD -9.79M 10.33M 2026-03
Ovoca Bio EUR -1.16M 4.48M 2025-06
Pacific Edge NZD -16.94M 2.46M 2026-06
Paradigm Biopharmaceuticals AUD -21.57M 13.07M 2025-12
Pharma Mar EUR 622K 42.99M 2026-03
Polynovo AUD 2.06M 1.18M 2025-12
PYC Therapeutics AUD -22.59M 9.12M 2025-12
Qiagen NV USD 116.63M 5.25M 2026-03
Ramsay Health Care AUD 541.1M 3.9M 2025-12
ResMed USD 499.81M 490K 2026-03
Sartorius EUR 164M 3.3M 2026-06
Sino Biopharmaceutical CNY 5.18B 3.32B 2025-06
Telix Pharmaceuticals AUD 8.04M 3.21M 2025-12
Tilray USD -20.01M 9.34M 2025-09
Zealand Pharma A/S -707.05M 245.73M 2025-12
Zz Pientze Pharmaceu CNY 837.81M 336.48M 2026-03